Second Reading of the Health and Social Care Bill: An open letter to MPs

Dear Member of Parliament, This afternoon the Health and Social Care Bill will recieve its Second Reading in the House of Commons.  The legislation sets out a far-reaching programme for reforming the NHS and the provision of patient care.  The Association of Medical Research Charities (AMRC) and its 127 member charities believe that high quality… Read More Second Reading of the Health and Social Care Bill: An open letter to MPs

Rawlins Review: Academy lays down law on health research regulation

Over the weekend Professor Colin Blakemore said he hoped the Academy of Medical Sciences would come up with radical proposals to end the regulatory mess that holds up UK health research such as clinical trials. I am not sure whether he will feel today’s report by the Academy lives up to that aspiration, but I do… Read More Rawlins Review: Academy lays down law on health research regulation

Regulating research – Blakemore/Deer comment pieces + AMRC background

Ahead of next week’s Academy of Medical Sciences (AMS) much anticipated report on medical research regulation I see  The Times and Sunday Times (both paywall) have published pieces this weekend by scientist Professor Colin Blakemore and journalist Brian Deer respectively, offering different perspectives on the issue of regulation. If you are looking for further background on… Read More Regulating research – Blakemore/Deer comment pieces + AMRC background

More NHS patients participating in UK clinical trials than ever before

A piece of good news with which to begin the New Year.  PharmaTimes is reporting that the number of patients participating in clinical trials jumped by 67% last year to over half a million (compared to over 300,000 in 2009). The new CEO of the National Institute for Health Research Clinical Research Network Co-ordinating Centre (NIHR… Read More More NHS patients participating in UK clinical trials than ever before

An evening of industry – how the pharma business model is changing

So it’s 10pm and I’m busy here putting the final touches to the AMRC/INVOLVE report of the workshop we held in November which drew together patient views on health research regulation.  This was at the invitation of the Academy of Medical Sciences as part of their review of regulation and governance but – and all… Read More An evening of industry – how the pharma business model is changing

When good medicine is the casualty of hype and ignorance

I have just returned from the Financial Times’ offices, where I was the guest for their regular science podcast hosted by Clive Cookson and Andrew Jack (it will appear here later today).  The theme of the discussion was ‘Selling Sickness.’  Andrew was reporting on a recent conference of the same name that took place last month in Holland. … Read More When good medicine is the casualty of hype and ignorance